These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14718607)

  • 61. Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans.
    Hajda J; Rentsch KM; Gubler C; Steinert H; Stieger B; Fattinger K
    Eur J Pharm Sci; 2010 Dec; 41(5):729-35. PubMed ID: 20933082
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery.
    Benet LZ; Izumi T; Zhang Y; Silverman JA; Wacher VJ
    J Control Release; 1999 Nov; 62(1-2):25-31. PubMed ID: 10518631
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Soybean Oil-Based Lipid Emulsion Increases Intestinal Permeability of Lipopolysaccharide in Caco-2 Cells by Downregulation of P-Glycoprotein via ERK-FOXO 3a Pathway.
    Yan JK; Zhu J; Gu BL; Yan WH; Xiao YT; Zhou KJ; Wen J; Wang Y; Cai W
    Cell Physiol Biochem; 2016; 39(4):1581-94. PubMed ID: 27627102
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of pluronic P123 and F127 block copolymer on P-glycoprotein transport and CYP3A metabolism.
    Guan Y; Huang J; Zuo L; Xu J; Si L; Qiu J; Li G
    Arch Pharm Res; 2011 Oct; 34(10):1719-28. PubMed ID: 22076772
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro.
    Granfors MT; Wang JS; Kajosaari LI; Laitila J; Neuvonen PJ; Backman JT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):79-85. PubMed ID: 16433896
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.
    Honda Y; Ushigome F; Koyabu N; Morimoto S; Shoyama Y; Uchiumi T; Kuwano M; Ohtani H; Sawada Y
    Br J Pharmacol; 2004 Dec; 143(7):856-64. PubMed ID: 15504753
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of spice constituents on P-glycoprotein-mediated transport and CYP3A4-mediated metabolism in vitro.
    Zhang W; Lim LY
    Drug Metab Dispos; 2008 Jul; 36(7):1283-90. PubMed ID: 18385293
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4.
    Takanaga H; Ohnishi A; Yamada S; Matsuo H; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    J Pharmacol Exp Ther; 2000 Apr; 293(1):230-6. PubMed ID: 10734174
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of budesonide on P-glycoprotein expression in intestinal cell lines.
    Maier A; Zimmermann C; Beglinger C; Drewe J; Gutmann H
    Br J Pharmacol; 2007 Feb; 150(3):361-8. PubMed ID: 17179942
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The consequence of regional gradients of P-gp and CYP3A4 for drug-drug interactions by P-gp inhibitors and the P-gp/CYP3A4 interplay in the human intestine ex vivo.
    Li M; de Graaf IA; van de Steeg E; de Jager MH; Groothuis GM
    Toxicol In Vitro; 2017 Apr; 40():26-33. PubMed ID: 27939799
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions.
    Decker CJ; Laitinen LM; Bridson GW; Raybuck SA; Tung RD; Chaturvedi PR
    J Pharm Sci; 1998 Jul; 87(7):803-7. PubMed ID: 9649346
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In Vitro and In Situ Characterization of the Intestinal Absorption of Capilliposide B and Capilliposide C from
    Zhang X; Cheng X; Wu Y; Feng D; Qian Y; Chen L; Yang B; Gu M
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30925820
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Overexpression of P-glycoprotein, MRP2, and CYP3A4 impairs intestinal absorption of octreotide in rats with portal hypertension.
    Sun X; Tang S; Hou B; Duan Z; Liu Z; Li Y; He S; Wang Q; Chang Q
    BMC Gastroenterol; 2021 Jan; 21(1):2. PubMed ID: 33407159
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effects of culture conditions on CYP3A4 and MDR1 mRNA induction by 1alpha,25-dihydroxyvitamin D(3) in human intestinal cell lines, Caco-2 and LS180.
    Aiba T; Susa M; Fukumori S; Hashimoto Y
    Drug Metab Pharmacokinet; 2005 Aug; 20(4):268-74. PubMed ID: 16141606
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Investigating the binding interactions of the anti-Alzheimer's drug donepezil with CYP3A4 and P-glycoprotein.
    McEneny-King A; Edginton AN; Rao PP
    Bioorg Med Chem Lett; 2015 Jan; 25(2):297-301. PubMed ID: 25499431
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine.
    Berggren S; Gall C; Wollnitz N; Ekelund M; Karlbom U; Hoogstraate J; Schrenk D; Lennernäs H
    Mol Pharm; 2007; 4(2):252-7. PubMed ID: 17263554
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Crohn's Disease Is Associated with Decreased CYP3A4 and P-Glycoprotein Protein Expression.
    Wilson A; Urquhart BL; Ponich T; Chande N; Gregor JC; Beaton M; Kim RB
    Mol Pharm; 2019 Sep; 16(9):4059-4064. PubMed ID: 31393129
    [TBL] [Abstract][Full Text] [Related]  

  • 78. N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs.
    Brandes LJ; Queen GM; LaBella FS
    Cancer Chemother Pharmacol; 2000; 45(4):298-304. PubMed ID: 10755318
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Alterations of CYP3A4 and P-glycoprotein activity in vivo with time in renal graft recipients.
    Lemahieu WP; Maes BD; Verbeke K; Vanrenterghem YF
    Kidney Int; 2004 Jul; 66(1):433-40. PubMed ID: 15200453
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modulation of P450 CYP3A4-dependent metabolism by P-glycoprotein: implications for P450 phenotyping.
    Baron JM; Goh LB; Yao D; Wolf CR; Friedberg T
    J Pharmacol Exp Ther; 2001 Feb; 296(2):351-8. PubMed ID: 11160617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.